Record €2.3 billion raise provides new capital to support approximately 30 biotech companies
Endpoints News’ article “Forbion gets Lilly’s backing in Dutch VC’s largest-ever fundraising haul” reports on Forbion’s €2.3 billion ($2.6 billion) fundraise across Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII—the firm’s largest fundraising to date.
The article highlights the participation of Eli Lilly and Company alongside institutional investors including MN, PGGM, KfW Capital and the Kauffman Foundation. The raise substantially exceeded its target and brings Forbion’s assets under management to approximately €7.5 billion.